BDBM419181 N-(4-ethylphenyl)-N- isobutyl-3-(S- methylsulfonimidoyl)-4-((1- (methylsulfonylpiperidin-4- yl)methoxy)benzene- sulfonamide::US10457637, Compound 51

SMILES CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(OCC2CCN(CC2)S(C)(=O)=O)c(c1)S(C)(=N)=O

InChI Key InChIKey=OPDVDWPTFOYMDS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 419181   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM419181(N-(4-ethylphenyl)-N- isobutyl-3-(S- methylsulfonim...)
Affinity DataIC50: >1.00E+3nMAssay Description:The RORγ transactivation model was developed from the line HG5LN, which is a HeLa line that stably expresses a luciferase reporter gene controll...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent